Search the Newsreel

Why Is Madison Square Garden Sports Stock Gaining Thursday? - Madison Square Garden (NYSE:MSGS)

Nomad Foods’ tough year continues in Q2, though profit rises on price increases

Nomad Foods experienced a challenging second quarter, though the company managed to increase its profit due to strategic price adjustments. The article indicates that despite ongoing difficulties, the firm is leveraging pricing power to maintain profitability. Further details are restricted to subscribers.

Madison Square Garden Sports (MSGS) Rides Lakers Sale Buzz, Is The Stock Fully Priced?

Nomad Foods slashes EPS forecast on debt restructuring

Nomad Foods has slashed its full-year EPS guidance as the Findus brand owner posted an anticipated decline in second-quarter sales and profits. The New York-listed frozen food group had flagged in July that it was "evaluating" its EPS outlook for fiscal 2026 as Nomad …

Lakers Sale, Knicks NBA Title Revenue Boost MSGS Stock

Madhav Marble Q1 Results: Standalone profit falls 30% YoY to ₹11.27 lakh

Earnings call transcript: Nomad Foods beats Q2 2026 estimates but shares fall

Nomad Foods reported Q2 2026 earnings and revenue that exceeded Wall Street estimates, with adjusted EPS of $0.39 against a $0.33 forecast and revenue of $724 million compared to a $710.9 million estimate. Despite the beat, shares dropped 7.02% in premarket trading due to …

Madison Square Garden Entertainment (NYSE:MSGE) Price Target Raised to $103.00

Should Value Investors Buy Kamada (KMDA) Stock?

Kamada (KMDA) is presented as a potential value investment, currently holding a Zacks Rank #2 (Buy) and a Value grade of A. The article highlights several favorable valuation metrics for KMDA, including its P/E ratio, PEG ratio, and P/B ratio, which are all lower …

Madison Square Garden Entertainment (MSGE) Stock May Be Fully Priced After Record Revenue

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Madison Square Garden Entertainment has delivered a very strong share price run over the past three years, while the latest valuation checks suggest the …

Nomad Foods Limited 2026 Q2 - Results - Earnings Call Presentation (NYSE:NOMD) 2026-08-13

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Nomad Foods (NOMD) is back in focus after its second quarter 2026 earnings release, which showed lower reported sales and earnings per share, …

Is Madison Square Garden Sports Corp (MSGS) Overvalued After Q4

Madison Square Garden (MSGS) Beats Q4 Earnings and Revenue Estimates

Madison Square Garden Sports stock rises 3% as Q4 earnings, revenue top estimates

Why Madison Pacific Properties Inc. stock plummeted yesterday

Nomad Foods (NOMD) Tops Q2 Earnings and Revenue Estimates

Nomad Foods (NOMD) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.45 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Why Is Nomad Foods Stock Falling Thursday? - Nomad Foods (NYSE:NOMD)

Madison Square Garden Sports earnings beat by $0.62, revenue topped estimates

Nomad Foods (NYSE:NOMD) Releases FY 2026 Earnings Guidance

Madison Square Garden: Fiscal Q4 Earnings Snapshot

Omada Health, Inc. (OMDA) Receives a Buy from Canaccord Genuity

Madison Square Garden Sports Corp. Reports Fiscal 2026 Fourth Quarter and Full-Year Results

Fiscal 2026 Highlighted by the New York Knicks Winning the NBA Championship Proposed Spin-off of New York Rangers Business Expected to be Completed by the End of October 2026 NEW YORK, August 13, 2026--(BUSINESS WIRE)--Madison Square Garden Sports Corp. (NYSE: MSGS) today reported financial …

Kamada Delivers Record First-Half 2026 Results and Secures $50 Million Plasma Supply Deal

Kamada announced record first-half 2026 revenues of $100.2 million and adjusted EBITDA of $25.7 million, driven by strong demand for its specialty plasma-derived therapies. The company reaffirmed its full-year 2026 guidance and secured a new three-year, $50 million plasma supply agreement to support its …

Nomad Foods Reports Second Quarter 2026 Financial Results

Pricing and productivity drove a positive Adjusted Gross Margin inflection Cash generation remains strong with Adjusted Free Cash Flow conversion higher year-on-year WOKING, England, Aug. 13, 2026 /PRNewswire/ -- Nomad Foods Limited (NYSE: NOMD), today reported financial results for the three and six month …

Armada Acquisition Corp. II (XRPN) details Ripple deal, XRP PIPEs and going concern in 10-Q

Armada Acquisition Corp. II (XRPN) filed its 10-Q, revealing $241.3 million in total assets, mainly in a trust account, and a net profit of $2.15 million for the nine months ending June 30, 2026. The SPAC faces a liquidation deadline of November 22, 2026, …

Madrigal Pharmaceuticals, Inc. Announces Appointment of John C. Reed as Board Director

Madrigal Pharmaceuticals, Inc. announced the appointment of John C. Reed, M.D., Ph.D., to its Board of Directors. Dr. Reed is currently Executive Vice President, Innovative Medicine, Research & Development at Johnson & Johnson and has held executive leadership positions at Sanofi and Roche. He …

Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors

Madrigal Pharmaceuticals, Inc. has appointed John C. Reed, M.D., Ph.D., to its Board of Directors. Dr. Reed is currently Executive Vice President, Innovative Medicine, Research & Development at Johnson & Johnson and brings extensive biopharma industry experience from previous executive roles at Sanofi and …

Kamada Releases Q2 2026 Financial Results

Kamada Ltd. reported strong Q2 2026 financial results, with adjusted earnings of $0.16 per share, significantly exceeding the $0.11 consensus. The company's revenue increased by 23.0% to $54.9M, and it achieved a net income of $9.3M. Kamada also provided full-year revenue guidance of $200.0M …

Dimensional Fund Advisors LP Has $4.46 Million Stock Holdings in Madrigal Pharmaceuticals, Inc. $MDGL

Dimensional Fund Advisors LP significantly reduced its stake in Madrigal Pharmaceuticals (NASDAQ:MDGL) by 55.9% in the first quarter, selling 10,801 shares and retaining 8,520 shares valued at approximately $4.46 million. Despite this reduction, institutional investors and hedge funds collectively own 98.5% of the company's …

Nomad Foods: Q2 Earnings Snapshot

Nomad Foods Ltd. reported a net income of $56.4 million in its second quarter, translating to a profit of 41 cents per share. After adjusting for non-recurring costs, earnings were 45 cents per share. The frozen foods company also announced revenues of $841.3 million …

Is Madison Square Garden Entertainment (MSGE) Fully Valued As Earnings Beat Lifts The Stock?

Is It Worth Considering Al Hammadi Holding Company (TADAWUL:4007) For Its Upcoming Dividend?

Kamada Announces Planned Transition of Chief Financial Officer

Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA) announced that its Chief Financial Officer, Chaime Orlev, will transition out of his role on December 31, 2026, to pursue other opportunities. Orlev has served as CFO since 2017 and will assist in the transition to a successor, …

Madison Square Garden Entertainment Q4 2026: Results Beat Estimates — Deep Dive

MSGE (MSGE) Q4 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 12, 2026 at 10:00 a.m. ET CALL PARTICIPANTS Senior Vice President, Investor Relations and Treasury - Ari DanesExecutive Vice President and Chief Financial Officer - David J. Collins TAKEAWAYS Full Year Revenue -- $1.1 billion, representing …

Omada Health (NASDAQ:OMDA) President Sells 8,866 Shares

Omada Health's President, Wei-Li Shao, sold 8,866 shares of OMDA stock for $221,827, reducing his direct stake by 2.8%. This sale occurred after Omada Health reported a strong second quarter, with EPS of $0.08 and revenue of $87.83 million, exceeding analyst expectations. Despite positive …